Editorial
doi: 10.1016/s0959-8049(97)00106-8.
Aromatase inhibitors for breast cancer--further progress
- PMID: 9376202
- DOI: 10.1016/s0959-8049(97)00106-8
Item in Clipboard
Editorial
Aromatase inhibitors for breast cancer--further progress
Eur J Cancer.
1997 Jun.
No abstract available
Comment on
-
Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90). Swiss Group for Clinical Cancer Research (SAKK).Eur J Cancer. 1997 Jun;33(7):1017-24. doi: 10.1016/s0959-8049(97)00105-6. Eur J Cancer. 1997. PMID: 9376181 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
